Skip to search formSkip to main contentSkip to account menu

Pylera

National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Bismuth subcitrate potassiumMetronidazoleTetracyclinebismuth subcitrate
bismuth subcitrate / Metronidazole / Tetracycline Oral Capsule [Pylera]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A novel hybrid first-line therapy for H . pylori eradication : results of a pilot study
Helicobacter pylori (H. pylori) eradication remains challenging in clinical practice. Current European guidelines recommend… 
2018
2018
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera®) in real-life clinical practice in Spain.
2018
2018
Retrospective analysis of the use of quadruple therapy with bismuth (Pylera®) in real-life clinical practice in Spain
2018
2018
P.01.7 EFFICACY OF TREATMENT WITH PYLERA ® IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER
2017
2017
Pylera® (bismuth subcitrate potassium/metronidazole/tetracycline hydrochloride) in the eradication of Helicobacter pylori infection: a profile of its use in Europe
Pylera® comprises three (bismuth substrate potassium + metronidazole + tetracycline hydrochloride) of four components of bismuth… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)